Rubio I, Pedreira F, Roca I, Cabaleiro A, Mendoza C, Córdoba O, Cortadellas T, Sabadell D, Xercavins J
Unidad de Patología Mamaria, Hospital Universitario Vall d'Hebron, Barcelona, Spain.
Clin Transl Oncol. 2008 Jun;10(6):347-50. doi: 10.1007/s12094-008-0210-0.
The aim of this study is to evaluate if it is necessary to remove all the radioactive sentinel lymph nodes (SLNs) not seen on lymphoscintigraphy in order to accurately stage breast cancer patients.
From March 1999 to March 2006, SLN biopsy was performed in 461 patients. All patients were only injected with radioisotope. Lymphoscintigraphy was performed in all the patients. The mean number of SLNs removed was 2.1 (range 1-15).
The SLN was positive in 133 patients (28.8%). Lymphoscintigraphy accurately predicted the number of SLNs identified intraoperatively in 243 patients (52.7%). In 175 patients (37.9%) there were more SLNs identified intraoperatively than were seen on lymphos cintigraphy. In 11 (6.2%) of these 175 patients, additional SLNs identified intraoperatively harboured metastasis. Type of injection, need for a second injection, tumour location and age were not identified as statistically significantly associated with additional positive SLNs identified intraoperatively and not seen on lymphoscintigraphy.
Lymphoscintigraphy does not accurately predict the number of SLNs identified intraoperatively, this number being underestimated. Surgeons should remove all radioactive SLNs to improve the detection of positive SLNs.
本研究旨在评估是否有必要切除所有在淋巴闪烁造影中未显示的放射性前哨淋巴结(SLN),以便准确地对乳腺癌患者进行分期。
1999年3月至2006年3月期间,对461例患者进行了前哨淋巴结活检。所有患者仅注射了放射性同位素。对所有患者均进行了淋巴闪烁造影。切除的前哨淋巴结平均数量为2.1个(范围为1至15个)。
133例患者(28.8%)的前哨淋巴结呈阳性。淋巴闪烁造影准确预测了243例患者(52.7%)术中发现的前哨淋巴结数量。175例患者(37.9%)术中发现的前哨淋巴结数量多于淋巴闪烁造影显示的数量。在这175例患者中的11例(6.2%)中,术中发现的额外前哨淋巴结存在转移。注射类型、是否需要二次注射、肿瘤位置和年龄与术中发现但淋巴闪烁造影未显示的额外阳性前哨淋巴结无统计学显著相关性。
淋巴闪烁造影不能准确预测术中发现的前哨淋巴结数量,该数量被低估。外科医生应切除所有放射性前哨淋巴结,以提高阳性前哨淋巴结的检出率。